濮阳东方医院男科技术很好(濮阳东方医院男科价格收费合理) (今日更新中)

While working to get out the vote, Amy Schumer revealed some exciting news on Monday.The actress is expecting her first child with husband, Chris Fischer.Schumer announced her pregnancy in an Instagram story about the upcoming midterm elections via journalist Jessica Yellin. Yellin shared some of Schumer's candidate recommendations for voters and directed followers to read to the bottom of a list where Schumer wrote, "I'm pregnant."Schumer, 37, teased the reveal in a separate Instagram post, sharing a photo of herself and her husband made to look like a pregnant Meghan Markle and Prince Harry.The couple married in an intimate outdoor ceremony in Malibu, California last February. Fischer is a James Beard award-winning chef and author.Beyond her work in film and television, Schumer is an advocate for equal rights and ending gun violence. Earlier this month, she was arrested as part of a demonstration against the Supreme Court nomination of Brett Kavanaugh. 996

White House communications director Hope Hicks is not answering questions about her time in the White House during her closed-door House Intelligence Committee testimony Tuesday, but she has started to answer some questions about the presidential transition, according to lawmakers on the committee.A source familiar with her testimony says the attorney for Hicks told the committee that she will not discuss matters after the campaign in accordance with the White House request. When asked about certain matters, her attorney says she will "take it under advisement" but not answer those questions, the source said.When former White House chief strategist Steve Bannon appeared before the committee last month and didn't answer questions about similar time frame beyond the 2016 campaign, he was hit with a subpoena during the interview. Republicans said Bannon's claim that he could invoke executive privilege?during the presidential transition did not have merit.Hicks, however, did respond to some questions regarding the transition, according to Rep. Tom Rooney, a Florida Republican.Rooney said her answers weren't prompted by a subpoena threat, but because she apparently had responded to similar questions during her previous interview before the Senate Intelligence Committee. The committee made the case they were entitled to the same answers as the Senate panel, and the White House apparently agreed."It had more to do with what she testified to the Senate, and what was fair to the House to ask the same questions," Rooney said.It's unclear whether Hicks is answering all questions about the transition or just those that she previously answered in her Senate testimony.Earlier on Tuesday, Democrats were pushing for the committee to subpoena Hicks for not responding to the panel's questions."We got Bannon-ed," said Rep. Denny Heck, a Washington state Democrat."I have less hope we'll get to all the answers," said Rep. Mike Quigley, an Illinois Democrat. "As with anyone who doesn't answer questions, they ought to be subpoenaed."Rooney and other lawmakers said Hicks still was not answering questions about her time in the Trump White House."There are some questions that she's not going to answer. I think anything dealing with the administration, from the time of the inauguration," GOP Rep. Chris Stewart of Utah told reporters.Rep. Mike Conaway, the Texas Republican leading the House Intelligence Committee's Russia investigation, told CNN ahead of the meeting that he expected Hicks to answer all of the committee's questions. He declined to comment Tuesday afternoon on Hicks' testimony or a possible subpoena, saying he would wait until the interview had concluded.Bannon returned under subpoena earlier this month to the committee to continue he testimony, and he told the panel he had been instructed by the White House to invoke executive privilege on behalf of the President.California Rep. Adam Schiff, the top Democrat on the House Intelligence Committee, has called for Bannon to be held in contempt of Congress for refusing to answer questions, as well as former Trump campaign manager Corey Lewandowski, who also limited the scope of questions he would answer. But Conaway said Tuesday that he still has to discuss the matter with House Speaker Paul Ryan before deciding how to proceed.Quigley said Hicks had not asserted privilege Tuesday, but she was "following the orders of the White House not to answer certain questions."Hicks did not answer reporter questions on her way into the interview Tuesday morning. She was initially scheduled to appear before the committee last month as part of the panel's investigation into Russian meddling into the US election, but her interview was delayed over questions about the scope of her testimony.Hicks has already been interviewed by the Senate Intelligence Committee, a source familiar with the matter told CNN. Hicks also met last year with?special counsel Robert Mueller as part of his investigation.Hicks, a trusted Trump aide for years, was one of then-candidate Trump's first hires as he put together an improbable run for the White House. During the campaign, she was often by Trump's side and attended nearly every rally, while she was in frequent communication with other senior officials as they coordinated their tactics to win the White House.The House panel plans to interview her about any knowledge she has of contacts that occurred between other Trump associates and Russians. And she is bound to be questioned about other controversies as well, namely the White House's involvement in crafting a misleading response last summer once a June 2016 meeting between Russians and Donald Trump Jr. was revealed in the press.Hicks appears to have firsthand knowledge of a number of key events that have shaped the first year of the Trump White House, including being on Air Force One when the initial misleading statement about Trump Jr.'s meeting with Russians was crafted. 4977

WEST PALM BEACH, Fla. -- Two specially modified shotguns and ammunition were stolen from Palm Beach Zoo in the hours between late Wednesday and early Thursday.Head of Communications & Public Relations for Palm Beach Zoo, Naki Carter, says someone broke into the zoo and pried open a gun safe that stored the weapons.The shotguns were used by the zoo's "critical response team" in cases of emergency.The zoo is offering a ,000 reward for the return of the weapons.When asked if this was thought to be an "inside job", Carter had no comment.If the perpetrator(s) is caught with the weapons, which require a federal permit, they could face 10 years in prison and a fine.Carter says Palm Beach Zoo has increased security measures since the theft, but will not go into detail as to what those measures entail. 828

When talking about veteran mental health, much of the conversation is centered on post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). While both are widespread and debilitating, the mental health-related challenges veterans face go beyond these conditions.Dependable, courageous, and in peak physical shape, Theresa Larson chased perfection when joining the Marine Corps.“I wanted to be the exemplary Marine," said Larson. "To the T. What does a good Marine officer do? I had to do that.”A stellar student and Division 1 college athlete, she had been training for a challenge like this her entire life. With two older brothers in the military, Larson was well aware of the unique challenges she'd face as a female leader. “You have to be really fit and healthy. You have to be fitter than them. They're going to look at you physically and see how you perform," said Larson.Leader of a platoon, Larson was responsible for more than 50 Marines, working to earn their respect while training them for war. “You already fit in if you’re a male, if you’re a female, it's what is she going to do for me? Kind of attitude. And I was prepared for that," said Larson.But chasing perfection would come at a cost; her own well-being was no longer a priority. As the 12 to 15-hour days and mounting pressure felt out of her control, Larson latched onto what she could control. “The drug was food for me, so it ended up turning into the bulimia end of the first year," said Larson.With rigid fitness standards and weight requirements, the National Eating Disorders Association says service members are at especially high risk for eating disorders.“Abuse of fitness and nutrition tends to be the thing. It might not be full-blown bulimia or anorexia, or anything like that, but it can be a lot of disordered eating. Obviously, with yo-yo dieting, too much exercise or too little exercise can affect your focus," said Larson.Before deploying to Iraq, Larson sought help from a friend but didn’t disclose her illness to the military, fearing she’d lose her job.“I tried to make everyone realize I would be OK because I didn’t want to let the Marines down. You know, mission accomplishment and troop welfare are kind of the things we thrive on as Marines, especially Marine leaders," said Larson. No longer at a desk, leading operations and landmine missions, the responsibility to protect her platoon had never felt greater."It dawned on me, 'gosh, I’m really not OK. And this is not about me. It's about all the Marines I’m taking care of. So yeah, I’m sick, and I’m going to affect someone else.' It was a wake-up call," said Larson.Larson was sent home and said she had to fight to get treatment in the military. While grateful they covered 12 weeks of care in an outpatient rehabilitation clinic, Larson says she was on her own to continue getting help.“Anyone knows that has an addiction, it’s not just a, 'OK, you're done.' It's a continuous, daily decision and practice. And so, I ended up paying for my own care after that for a while," said Larson. "It was a couple of years until I stopped the symptoms of bulimia, and then was just dealing with what was left-- the depression, the anxiety, and managing that.”She says getting healthy became her job. And after the military, Larson helped others do the same. She wrote a memoir about her military experience and has since been contacted by countless service members and veterans struggling with similar challenges. “As a leader, there's a fine line of when you push yourself and when you need to ask for help. And asking for help, I’ve learned, is not a weakness. It’s a strength," said Larson.After earning a doctorate in physical therapy, Larson and her husband founded Movement Rx, a program helping people around the country uncover the root cause of their pain and injuries. “Just because someone is in a wheelchair, that’s not the only thing going on. Or if someone looks like they’re fine, it doesn’t mean they don’t have something going on," said Larson. In addition to free online resources for veterans, Movement Rx has free in-person training for veterans in San Diego. “We have our health care platform that veterans can use, offering mindfulness and meditation, nutrition support, fitness, as well as movement, working through injuries," said Larson. While there's more help now for struggling veterans and service members, Larson knows asking for it is still just as hard. “You asking for help, it's going to open more doors and more growth than you can ever imagine, but you have to take that vulnerable leap, and that's when life really happens." 4633

With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to fight the virus right away, without having to train the immune system to make them.Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines work by tricking the body into thinking there’s an infection so it makes antibodies and remembers how to do that if the real bug turns up.But it can take a month or two after vaccination or infection for the most effective antibodies to form. The experimental drugs shortcut that process by giving concentrated versions of specific ones that worked best against the coronavirus in lab and animal tests.“A vaccine takes time to work, to force the development of antibodies. But when you give an antibody, you get immediate protection,” said University of North Carolina virologist Dr. Myron Cohen. “If we can generate them in large concentrations, in big vats in an antibody factory ... we can kind of bypass the immune system.”These drugs are believed to last for a month or more and could give quick, temporary immunity to people at high risk of infection, such as health workers and housemates of someone with COVID-19. If they proved effective and if a vaccine doesn’t materialize or protect as hoped, the drugs might eventually be considered for wider use, perhaps for teachers or other groups.They’re also being tested as treatments, to help the immune system and prevent severe symptoms or death.“The hope there is to target people who are in the first week of their illness and that we can treat them with the antibody and prevent them from getting sick,” said Dr. Marshall Lyon, an infectious disease specialist helping to test one such drug at Emory University in Atlanta.Having such a tool “would be a really momentous thing in our fight against COVID,” Cohen said.Vaccines are seen as a key to controlling the virus, which has been confirmed to have infected more than 20 million people worldwide and killed more than 738,000. Several companies are racing to develop vaccines, but the results of the large final tests needed to evaluate them are months away.The antibody drugs are “very promising” and, in contrast, could be available “fairly soon,” said Dr. Janet Woodcock, a U.S. Food and Drug Administration official who is leading government efforts to speed COVID-19 therapies. Key studies are underway and some answers should come by early fall.One company, Eli Lilly, has already started manufacturing its antibody drug, betting that studies now underway will give positive results.“Our goal is to get something out as soon as possible” and to have hundreds of thousands of doses ready by fall, said Lilly’s chief scientific officer, Dr. Daniel Skovronsky.Another company that developed an antibody drug cocktail against Ebola — Regeneron Pharmaceuticals Inc. — now is testing one for coronavirus.“The success with our Ebola program gives us some confidence that we can potentially do this again,” said Christos Kyratsous, a Regeneron microbiologist who helped lead that work.Regeneron’s drug uses two antibodies to enhance chances the drug will work even if the virus evolves to evade action by one.Lilly is testing two different, single-antibody drugs — one with the Canadian company AbCellera and another with a Chinese company, Junshi Biosciences. In July, Junshi said no safety concerns emerged in 40 healthy people who tried it and that larger studies were getting underway.Others working on antibody drugs include Amgen and Adaptive Biotechnologies. The Singapore biotech company Tychan Pte Ltd. also is testing an antibody drug and has similar products in development for Zika virus and yellow fever.“I’m cautiously optimistic” about the drugs, said the nation’s top infectious diseases expert, Dr. Anthony Fauci. “I’m heartened by the experience that we had with Ebola,” where the drugs proved effective.What could go wrong?— The antibodies may not reach all of the places in the body where they need to act, such as deep in the lungs. All the antibody drugs are given through an IV and must make their way through the bloodstream to wherever they’re needed.— The virus might mutate to avoid the antibody — the reason Regeneron is testing a two-antibody combo that binds to the virus in different places to help prevent its escape.Skovronsky said Lilly stuck with one antibody because manufacturing capacity would essentially be cut in half to make two, and “you will have less doses available.” If a single antibody works, “we can treat twice as many people,” he said.— The antibodies might not last long enough. If they fade within a month, it’s still OK for treatment since COVID-19 illness usually resolves in that time. But for prevention, it may not be practical to give infusions more often than every month or two.A San Francisco company, Vir Biotechnology Inc., says it has engineered antibodies to last longer than they usually do to avoid this problem. GlaxoSmithKline has invested 0 million in Vir to test them.Giving a higher dose also may help. If half of antibodies disappear after a month, “if you give twice as much, you will have two months’ protection,” Lilly’s Skovronsky said.— The big fear: Antibodies may do the opposite of what’s hoped and actually enhance the virus’s ability to get into cells or stimulate the immune system in a way that makes people sicker. It’s a theoretical concern that hasn’t been seen in testing so far, but large, definitive experiments are needed to prove safety.“As best as we can tell, the antibodies are helpful,” Lyon said.___Marilynn Marchione can be followed on Twitter: @MMarchioneAP___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 5919

来源：资阳报